true

Rheumatology, Inflammation, and Immunity Research

The Division of Rheumatology, Inflammation, and Immunity has one of the largest research funding bases and investigative teams of any rheumatology program in the country.
style
palette-deep-blue

Overview

The discoveries of our researchers in the areas of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and many other rheumatic diseases have transformed the practice of rheumatology and continue to improve the prognosis for patients.

Researchers in our division are investigating the underlying causes of rheumatic, inflammatory and immunologic disorders and are developing groundbreaking approaches to prevention and treatment. We study the full range of rheumatic diseases, including osteoarthritis, RA, lupus, gout, psoriatic arthritis and vasculitis and many others. Since the division's inception in 1974, our research has been continuously funded by the National Institutes of Health. Our annual research funding is over $50 million in direct costs yearly, with the largest portion coming from NIH. Our research team includes over 50 research faculty, many with large investigative teams.

Clinical Research
Bringing together outstanding clinicians and cutting edge scientists, we aim to accelerate breakthroughs and the translation of advances into precision medicine and personalized patient care.

primary

internal-arrow

Learn more

/content/research-xwalk/en/institutes-centers/research-at-the-department-of-medicine/rheumatology-inflammation-immunity/clinical-research

Basic/Translational Research
We aim to define fundamental mechanisms of immune and inflammatory diseases and to translate these findings into new therapies for autoimmune and inflammatory diseases and new biomarkers to advance precision medicine in rheumatology.

primary

internal-arrow

Learn more

/content/research-xwalk/en/institutes-centers/research-at-the-department-of-medicine/rheumatology-inflammation-immunity/basic-translational-research

Fellowships and trainings

Rheumatology Education and Training

We are committed to training exceptional clinicians, future leaders and life-long learners who provide expert, compassionate care to patients across the full spectrum of rheumatic disease.
https://assets.massgeneralbrigham.org/adobe/assets/urn:aaid:aem:02a68d92-8beb-4a0f-aae6-1fbcbba440ca/as/Rheum-Ed.avif?assetname=Rheum+Ed.png
primary
internal-arrow
Explore our training opportunities
https://research.massgeneralbrigham.org/en/education-and-training/graduate-medical-education/training-opportunities-search-results?q=rheumatology
style
palette-white
showJumplinks
true

Patient-centered research

Clinical trials of new therapies for rheumatic diseases are a critically important aspect of our division's research mission. Our active clinical trials program encompasses both observational and interventional studies in rheumatoid arthritis (RA), lupus, psoriatic arthritis, ankylosing spondylitis and other rheumatic diseases.
https://assets.massgeneralbrigham.org/adobe/assets/urn:aaid:aem:0e3cabe0-8e06-43b1-9844-e81cbae5d2f0/as/Rheum-research.avif?assetname=Rheum+research.png
primary
external
Visit the Rally website to find relevant trials
https://rally.massgeneralbrigham.org/
style
palette-light-teal
showJumplinks
true